Meyer Plc Board to Approve Q1 2026 Results on April 27

Meyer Plc has notified the NGX that its Board of Directors will meet on April 27, 2026 to consider and approve its unaudited financial statements for the first quarter ended March 31, 2026. This triggers a mandatory closed period barring all insiders from trading the company's shares until 24 hours after the results are published.
Meyer Plc has disclosed to the Nigerian Exchange Limited that its Board of Directors is scheduled to meet on Monday, April 27, 2026, to consider and approve the company's Unaudited Financial Statements for the first quarter ended March 31, 2026 (Q1 2026 UFS). The disclosure, signed by Company Secretary Kalu O. Kalu of Marriot Solicitors, was filed on April 13, 2026.
In line with NGX Amended Closed Period Rules, a closed period commenced on April 1, 2026, and will remain in force until 24 hours after the Q1 results are officially released to the exchange and the general public. During this window, all insiders and their connected persons are strictly prohibited from buying, selling, transferring, or otherwise dealing in Meyer Plc shares.
For retail investors, the closed period itself carries no positive or negative signal about the company's financial performance — it is a routine regulatory requirement designed to prevent insider trading ahead of material financial disclosures. What matters is the content of the Q1 2026 results expected shortly after April 27. Investors should watch for the official release of Meyer Plc's Q1 2026 figures on the NGX platform and assess revenue trends, profitability, and any management commentary before making investment decisions.
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories

Meyer Plc AGM 2026: Dividend Approved, PKF Named Auditor

Meyer Plc Declares 45 Kobo Dividend for FY 2025

Meyer Plc AGM 2026: Dividend, Director Elections & Auditors

Consolidated Hallmark Holdings Board Meeting April 2026

Neimeth International Pharmaceuticals Q1 2026 Board Meeting Date

Neimeth International Pharmaceuticals Q1 2026 Board Meeting Outcome
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.






